Immunonutrition Decreases Postoperative Complications in Gastrointestinal Cancer-A Systematic Review and Meta-analysis of Randomized Controlled Trials
Abstract
Current evidence supports the role of immunonutrition support (IMNS) to improve surgical outcomes in gastrointestinal (GI) cancer, but the optimal formula and prescription timing remain unclear. This systematic review and meta-analysis aimed to evaluate the efficacy of IMNS on postoperative outcomes in patients with GI cancer. The systematic search was conducted in 3 databases (PubMed, Embase, and Cochrane Library) in March 2024. The protocol was registered at PROSPERO under registration number CRD42024524537. Studies were selected based on the PICOS framework. Population: patients with GI cancer; Intervention: IMNS; Comparator: isonitrogenous and isocaloric supplementation, or standard care; Outcome: mortality, length of hospital stay, and postoperative complications; study design: randomized controlled trial (RCT). Random-effects models were used to calculate pooled odds ratios (OR) or mean differences with 95% confidence intervals (CIs). A total of 90 RCTs were included in the systematic review, with 55 eligible for meta-analysis. Data from 7462 patients were analyzed. IMNS formula based on arginine, nucleotides, and omega-3 (n-3) fatty acids, administered perioperatively, orally or enterally, significantly reduced the odds of anastomotic leak (OR = 0.62; 95% CI: 0.50, 0.76), infectious complications [e.g., respiratory (OR = 0.46; 95% CI: 0.33, 0.64), urinary (OR = 0.58; 95% CI: 0.38, 0.89), wound (OR = 0.67; 95% CI: 0.46, 0.98), and sepsis (OR = 0.45; 95% CI: 0.28,…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 7,462 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.